Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Spring;14(2):95-107.

Cholestasis and behavioral disorders

Affiliations
Review

Cholestasis and behavioral disorders

Delaram Eslimi Esfahani et al. Gastroenterol Hepatol Bed Bench. 2021 Spring.

Abstract

Acute and chronic failure in liver function may give rise to cognitive and non-cognitive impairments in the brain, namely hepatic encephalopathy (HE). Liver diseases may cause cholestasis, which is defined as the impaired secretion of bile. It is characterized by the accumulation of substances in plasma that are normally excreted in bile such as bile acids. Cholestasis can lead to hepatic encephalopathy. Several investigations have indicated that HE induces several symptoms, such as the impairment of learning and memory, anxiolytic-like behaviors, alterations in sleep pattern, and tremors. It has been reported that after HE, all classical neurotransmitter systems such as opioidergic, dopaminergic, cholinergic, GABAergic, adrenergic, serotonergic, and glutamatergic systems can be altered. This review focuses on cholestasis, hepatic encephalopathy, and behavioral disorders.

Keywords: Acute liver failure; Cognitive impairments; Neurotransmitter systems.

PubMed Disclaimer

References

    1. Pantiga C, Rodrigo LR, Cuesta M, Lopez L, Arias JL. Cognitive defi cits in patients with hepatic cirrhosis and in liver transplant recipients. J Neuropsychiatry Clin Neurosci. 2003;15:84–9. - PubMed
    1. Marquez-Aguirre AL, Canales-Aguirr AA, Gomez-Pinedo U, Galvez-Gastelum FJ. Molecular aspects of hepatic encephalopathy. Neurologia. 2010;25:239–47. - PubMed
    1. Ferenci p. Hepatic encephalopathy. Gastroenterol Rep. 2017;5:138–47. - PMC - PubMed
    1. Thornton JR, Losowsky MS. Opioid peptides and primary biliary cirrhosis. BMJ. 1988;297:1501–4. - PMC - PubMed
    1. Bergasa NV, Rothman RB, Vergalla J, Xu H, Swain MG, Jones EA. Central mu-opioid receptors are down-regulated in a rat model of cholestasis. J Hepatol. 1992;15:220–4. - PubMed

LinkOut - more resources